期刊文献+

血脂康胶囊合痛瘀消散贴外敷治疗糖尿病下肢动脉狭窄317例 被引量:4

下载PDF
导出
摘要 目的:观察血脂康胶囊内服合痛瘀消散贴局部外敷治疗糖尿病下肢动脉狭窄的临床效果。方法:对糖尿病合并下肢动脉狭窄的患者,在严格控制血糖达标,对症治疗其他基础病条件下,给予血脂康胶囊2粒,3次/d,痛瘀消散贴局部外敷,用药期间戒烟,可适量饮酒,但以白酒每日不超过15mL为量,限制高热量饮食,配合自身按摩,以1个月为1个疗程。结果:317例住院患者治疗1~5个疗程后,痊愈111例,有效171例,无效35例,总有效率达88.98%。结论:血脂康胶囊内服,痛瘀消贴膏外敷治疗糖尿病合并下肢动脉狭窄有较好的疗效。
出处 《甘肃中医》 2010年第2期50-51,共2页 Gansu Journal of Traditional Chinese Medicine
  • 相关文献

参考文献5

二级参考文献31

  • 1Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 2Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 3Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 4Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 5Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 6Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 7Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 8Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 9Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.
  • 10Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,2003,361:2005-2016.

共引文献712

同被引文献51

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部